Tapering off Inhaled Corticosteroids in Asthma patients after Reduction of Allergens

Completed

• Conditions: Asthma, Allergy; Respiratory; Asthma

• Registration Number: ISRCTN32862552
• Lead Sponsor: Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. Age 16-60 years
2. Treatment for asthma by the GP
3. Use of inhaled corticosteroids
4. Allergy for house dust mite allergens

Exclusion Criteria

1. Serious diseases other than asthma with a low survival rate
2. Other diseases, which influence bronchial symptoms and/or lung function
3. Exacerbation within one month before the start of the study
4. The use of oral steroids or inhaled cromoglycates
5. Use of house dust mite impermeable mattress/bedding covers
6. Allergy to cats or dogs while keeping these pets

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
se of inhaled corticosteroids

Secondary Outcome Measures

Name	Time	Method
1. Asthma control<br>2. Symptoms (dyspnoea, wheezing, coughing)<br>3. Peak flow parameters (morning peak flow, peak flow variability)